Metabolic & GLP-1 peptides
Incretins and metabolic peptides — GLP-1, semaglutide, tirzepatide, and related science.
In this cluster
52 peptide profilesGLP-1
30 aaGlucagon-like peptide-1 (GLP-1) is a 30–31-residue incretin hormone released by intestinal L-cells after a meal. It potentiates glucose-depe…
Semaglutide
31 aaSemaglutide is a 31-amino-acid GLP-1 receptor agonist peptide (C187H291N45O59, ≈4,114 Da). It keeps 94% of the human GLP-1 sequence but subs…
MOTS-c
16 aaMOTS-c is a 16-amino-acid peptide (MRWQEMGYIFYPRKLR; C101H152N28O22S2, ≈2,175 Da) encoded by a short open reading frame inside the mitochond…
Exendin-4
39 aaExendin-4 is a 39-residue peptide from Gila monster venom that activates the GLP-1 receptor and inspired the drug exenatide.
Tirzepatide
39 aaTirzepatide is a 39-amino-acid synthetic peptide (C225H348N48O68, ≈4,814 Da) that activates both the GIP and GLP-1 receptors. Its backbone i…
Retatrutide
39 aaRetatrutide (LY3437943) is an investigational 39-amino-acid peptide (C221H342N46O68, ≈4,731 Da) that activates three receptors — GIP, GLP-1 …
AOD-9604
16 aaAOD-9604 is a synthetic 16-residue peptide based on the C-terminal region of human growth hormone (residues 177–191 with an added N-terminal…
Cagrilintide
37 aaCagrilintide is an investigational 37-amino-acid analogue of the pancreatic hormone amylin (C194H312N54O59S2, ≈4,409 Da). Six substitutions …
Survodutide
29 aaSurvodutide (BI 456906) is an investigational 29-amino-acid glucagon-based peptide (C192H289N47O61, ≈4,232 Da) that activates both the gluca…
Mazdutide
34 aaMazdutide (IBI362 / LY3305677) is a once-weekly oxyntomodulin-based peptide (C207H317N45O65, ≈4,476 Da) that activates the GLP-1 and glucago…
Adipotide
Adipotide (Prohibitin-TP01) is an experimental chimeric peptidomimetic that pairs a homing sequence targeting adipose-tissue blood vessels w…
Liraglutide
31 aaLiraglutide is a once-daily GLP-1 receptor agonist peptide: human GLP-1(7-37) with one substitution (Lys34→Arg) and a C16 palmitic acid atta…
Dulaglutide
Dulaglutide (Trulicity) is a once-weekly GLP-1 receptor agonist built as a fusion protein: two DPP-4-resistant GLP-1 analogue chains linked …
Setmelanotide
8 aaSetmelanotide is a synthetic cyclic octapeptide that selectively activates the melanocortin-4 receptor (MC4R), a signaling hub in the brain'…
Pramlintide
37 aaPramlintide is a synthetic analog of the pancreatic hormone amylin, designed with proline substitutions so it stays soluble rather than aggr…
Amylin
37 aaAmylin, or islet amyloid polypeptide (IAPP), is a 37-residue peptide hormone co-secreted with insulin from pancreatic beta cells. It is stud…
Glucagon
29 aaGlucagon is a 29-amino-acid peptide hormone from pancreatic alpha cells that raises blood glucose, opposing insulin. It is the archetypal co…
Oxyntomodulin
37 aaOxyntomodulin is a 37-amino-acid gut hormone released from intestinal L-cells after eating. Because it activates both the GLP-1 and glucagon…
GIP
42 aaGIP (glucose-dependent insulinotropic polypeptide) is a 42-amino-acid incretin hormone released from intestinal K-cells after meals, where i…
Secretin
27 aaSecretin is a 27-amino-acid hormone released from duodenal S-cells in response to stomach acid entering the small intestine. Discovered by B…
Motilin
22 aaMotilin is a 22-amino-acid gut hormone secreted by endocrine cells of the small intestine. It coordinates the migrating motor complex, the w…
Peptide YY
36 aaPeptide YY (PYY) is a 36-amino-acid gut hormone released from intestinal L-cells after eating, where it contributes to satiety and slows gas…
Obestatin
23 aaObestatin is a 23-amino-acid peptide cleaved from the same preproghrelin precursor that produces ghrelin. It was originally proposed to oppo…
Nesfatin-1
82 aaNesfatin-1 is a peptide cleaved from the precursor protein nucleobindin-2 (NUCB2), produced in the hypothalamus and in peripheral tissues. I…
Cholecystokinin
8 aaCholecystokinin (CCK) is a peptide hormone and neurotransmitter released from intestinal I-cells and also produced widely in the brain. It t…
Gastrin
Gastrin is a peptide hormone released by G-cells of the gastric antrum that stimulates acid secretion from the stomach's parietal cells. Cir…
Lixisenatide
44 aaLixisenatide is a synthetic GLP-1 receptor agonist built on the exendin-4 scaffold rather than on human GLP-1. Marketed as Lyxumia and Adlyx…
Albiglutide
Albiglutide is a GLP-1 receptor agonist created by genetically fusing two modified GLP-1 sequences to human serum albumin, giving it a long …
Efpeglenatide
Efpeglenatide is a long-acting GLP-1 receptor agonist built from an exendin-based peptide conjugated to an antibody Fc fragment for extended…
Teduglutide
33 aaTeduglutide is a synthetic 33-amino-acid analog of glucagon-like peptide-2 (GLP-2). A single alanine-to-glycine substitution extends its hal…
Linaclotide
14 aaLinaclotide is a synthetic 14-amino-acid peptide that activates guanylate cyclase-C on the intestinal lining, raising cyclic GMP and driving…
Plecanatide
16 aaPlecanatide (Trulance) is a synthetic 16-residue analogue of human uroguanylin (NDECELCVNVACTGCL, two disulfides) that activates guanylate c…
Apelin
Apelin is an endogenous peptide hormone processed from a 77-amino-acid precursor into active fragments such as apelin-13 and apelin-36. It i…
Adropin
76 aaAdropin is a secreted peptide encoded by the energy homeostasis-associated gene (ENHO) and first described in 2008. Its 76-residue sequence …
Spexin
14 aaSpexin (neuropeptide Q) is a 14-amino-acid endogenous peptide discovered by bioinformatic analysis in 2007. It signals through galanin recep…
Glucagon-like peptide-2
33 aaGlucagon-like peptide-2 (GLP-2) is a 33-amino-acid gut hormone produced from proglucagon in intestinal L cells and co-released with GLP-1. A…
Uroguanylin
16 aaUroguanylin is a 16-amino-acid peptide secreted by enterochromaffin cells of the duodenum and encoded by GUCA2B. As an endogenous guanylate …
Cotadutide
30 aaCotadutide (MEDI0382) is a synthetic peptide engineered as a balanced dual agonist of the GLP-1 and glucagon receptors. It is an investigati…
Pemvidutide
Pemvidutide (ALT-801) is an investigational dual GLP-1/glucagon receptor agonist developed by Altimmune and studied in clinical trials for o…
Efinopegdutide
Efinopegdutide (MK-6024) is an investigational once-weekly GLP-1/glucagon receptor co-agonist peptide being developed by Merck for metabolic…
Beinaglutide
30 aaBeinaglutide is a recombinant human GLP-1(7-36) that shares 100% sequence identity with native human GLP-1. Approved in China for type 2 dia…
Amycretin
Amycretin (NN9487) is an investigational Novo Nordisk peptide that activates both the GLP-1 receptor and amylin receptors from a single chai…
Exenatide
39 aaExenatide is the synthetic form of exendin-4, a 39-residue peptide from Gila monster venom that activates the GLP-1 receptor. It was the fir…
Maridebart cafraglutide
Maridebart cafraglutide (MariTide, AMG 133) is an investigational antibody–peptide conjugate from Amgen: an antibody that antagonises the GI…
Petrelintide
36 aaPetrelintide (ZP8396) is an investigational long-acting analogue of human amylin developed by Zealand Pharma as a dual amylin and calcitonin…
Eloralintide
Eloralintide (LY3841136) is an investigational once-weekly amylin analogue from Eli Lilly that preferentially activates the amylin 1 recepto…
Ecnoglutide
Ecnoglutide (XW003) is a long-acting, cAMP-biased GLP-1 receptor agonist from Sciwind Biosciences: a human GLP-1 analogue with an Ala8Val su…
Dapiglutide
Dapiglutide (ZP7570) is an investigational long-acting peptide from Zealand Pharma that activates both the GLP-1 and GLP-2 receptors, aiming…
Dasiglucagon
29 aaDasiglucagon (Zegalogue) is a 29-amino-acid glucagon analogue with seven amino-acid substitutions, including Aib at position 16, that make i…
Glepaglutide
39 aaGlepaglutide (ZP1848) is a 39-amino-acid long-acting analogue of glucagon-like peptide-2 with a C-terminal hexa-lysine extension, developed …
Apraglutide
33 aaApraglutide (FE 203799) is a synthetic 33-amino-acid analogue of glucagon-like peptide-2 with four substitutions (Ala2→Gly, Met10→Ahx, Asn11…
C-peptide
31 aaC-peptide is the 31-amino-acid connecting peptide released when proinsulin is cleaved into insulin, produced in equimolar amounts with insul…
The incretin & metabolic co-agonist class at a glance
| Peptide | Receptors | Length | Mass (Da) | Half-life | Status |
|---|---|---|---|---|---|
| GLP-1 | GLP-1R | 30 aa | ≈ 3,297.6 | ≈ 1–2 min (DPP-4 cleavage + renal clearance) | Endogenous hormone — not a product |
| Liraglutide | GLP-1R | 31 aa | ≈ 3,751.2 | ≈ 13 h (once-daily dosing) | Approved: Victoza (2010, T2D), Saxenda (2014, weight) |
| Semaglutide | GLP-1R | 31 aa | ≈ 4,113.6 | ≈ 7 days (≈ 145–165 h in clinical PK studies) | Approved: Ozempic (2017, T2D), Rybelsus (2019, oral T2D), Wegovy (2021, weight) |
| Tirzepatide | GIPR + GLP-1R | 39 aa | ≈ 4,813.5 | ≈ 5 days (≈ 117 h) | Approved: Mounjaro (2022, T2D), Zepbound (2023, weight; 2024, obstructive sleep apnoea) |
| Retatrutide | GIPR + GLP-1R + GCGR | 39 aa | ≈ 4,731 | ≈ 6 days | Investigational (phase 3) |
| Cagrilintide | Amylin / calcitonin | 37 aa | ≈ 4,409 | ≈ 7–8 days (159–195 h across doses in the phase 1b study) | Investigational (phase 3, as CagriSema with semaglutide) |
| Survodutide | GCGR + GLP-1R | 29 aa | ≈ 4,232 | Supports once-weekly dosing (published population estimates are on the order of several days) | Investigational (phase 3: SYNCHRONIZE obesity programme; MASH programme) |
| Mazdutide | GCGR + GLP-1R | 34 aa | ≈ 4,476 | Supports once-weekly dosing (published estimates are on the order of several days) | Approved in China (NMPA): chronic weight management (27 June 2025) and type 2 diabetes (2025) |
| Amycretin | GLP-1R + amylin | — | — | Supports once-weekly subcutaneous dosing | Investigational (phase 2 results published 2025; later-phase trials under way) |
Verified from PubChem, IUPHAR and the primary discovery papers cited on each profile. Half-lives are approximate population means from published pharmacokinetics.